144 related articles for article (PubMed ID: 30858538)
1. Combination of cytokine-enhanced vaccine and chemo-gene therapy as surgery adjuvant treatments for spontaneous canine melanoma.
Finocchiaro LME; Agnetti L; Fondello C; Glikin GC
Gene Ther; 2019 Nov; 26(10-11):418-431. PubMed ID: 30858538
[TBL] [Abstract][Full Text] [Related]
2. Cytokine-Enhanced Vaccine and Interferon-β plus Suicide Gene Therapy as Surgery Adjuvant Treatments for Spontaneous Canine Melanoma.
Finocchiaro LM; Fondello C; Gil-Cardeza ML; Rossi ÚA; Villaverde MS; Riveros MD; Glikin GC
Hum Gene Ther; 2015 Jun; 26(6):367-76. PubMed ID: 25762364
[TBL] [Abstract][Full Text] [Related]
3. Cytokine-enhanced vaccine and suicide gene therapy as surgery adjuvant treatments for spontaneous canine melanoma: 9 years of follow-up.
Finocchiaro LM; Glikin GC
Cancer Gene Ther; 2012 Dec; 19(12):852-61. PubMed ID: 23059870
[TBL] [Abstract][Full Text] [Related]
4. Cytokine-enhanced vaccine and suicide gene therapy as surgery adjuvant treatments for spontaneous canine melanoma.
Finocchiaro LM; Glikin GC
Gene Ther; 2008 Feb; 15(4):267-76. PubMed ID: 18033308
[TBL] [Abstract][Full Text] [Related]
5. Adjuvant therapy for melanoma in dogs: results of randomized clinical trials using surgery, liposome-encapsulated muramyl tripeptide, and granulocyte macrophage colony-stimulating factor.
MacEwen EG; Kurzman ID; Vail DM; Dubielzig RR; Everlith K; Madewell BR; Rodriguez CO; Phillips B; Zwahlen CH; Obradovich J; Rosenthal RC; Fox LE; Rosenberg M; Henry C; Fidel J
Clin Cancer Res; 1999 Dec; 5(12):4249-58. PubMed ID: 10632367
[TBL] [Abstract][Full Text] [Related]
6. Suicide gene and cytokines combined nonviral gene therapy for spontaneous canine melanoma.
Finocchiaro LM; Fiszman GL; Karara AL; Glikin GC
Cancer Gene Ther; 2008 Mar; 15(3):165-72. PubMed ID: 18219342
[TBL] [Abstract][Full Text] [Related]
7. Cytokine-enhanced vaccine and interferon-β plus suicide gene as combined therapy for spontaneous canine sarcomas.
Finocchiaro LM; Villaverde MS; Gil-Cardeza ML; Riveros MD; Glikin GC
Res Vet Sci; 2011 Oct; 91(2):230-4. PubMed ID: 21300385
[TBL] [Abstract][Full Text] [Related]
8. Use of adjuvant carboplatin for treatment of dogs with oral malignant melanoma following surgical excision.
Dank G; Rassnick KM; Sokolovsky Y; Garrett LD; Post GS; Kitchell BE; Sellon RK; Kleiter M; Northrup N; Segev G
Vet Comp Oncol; 2014 Mar; 12(1):78-84. PubMed ID: 22737988
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of systemic adjuvant therapies administered to dogs after excision of oral malignant melanomas: 151 cases (2001-2012).
Boston SE; Lu X; Culp WT; Montinaro V; Romanelli G; Dudley RM; Liptak JM; Mestrinho LA; Buracco P
J Am Vet Med Assoc; 2014 Aug; 245(4):401-7. PubMed ID: 25075823
[TBL] [Abstract][Full Text] [Related]
10. A retrospective review of outcome and survival following surgery and adjuvant xenogeneic DNA vaccination in 32 dogs with oral malignant melanoma.
Treggiari E; Grant JP; North SM
J Vet Med Sci; 2016 Jun; 78(5):845-50. PubMed ID: 26781703
[TBL] [Abstract][Full Text] [Related]
11. Outcome following curative-intent surgery for oral melanoma in dogs: 70 cases (1998-2011).
Tuohy JL; Selmic LE; Worley DR; Ehrhart NP; Withrow SJ
J Am Vet Med Assoc; 2014 Dec; 245(11):1266-73. PubMed ID: 25406707
[TBL] [Abstract][Full Text] [Related]
12. Safety and efficacy of a xenogeneic DNA vaccine encoding for human tyrosinase as adjunctive treatment for oral malignant melanoma in dogs following surgical excision of the primary tumor.
Grosenbaugh DA; Leard AT; Bergman PJ; Klein MK; Meleo K; Susaneck S; Hess PR; Jankowski MK; Jones PD; Leibman NF; Johnson MH; Kurzman ID; Wolchok JD
Am J Vet Res; 2011 Dec; 72(12):1631-8. PubMed ID: 22126691
[TBL] [Abstract][Full Text] [Related]
13. Use of the melanoma vaccine in 38 dogs: The South African experience.
McLean JL; Lobetti RG
J S Afr Vet Assoc; 2015 Apr; 86(1):1246. PubMed ID: 26016668
[TBL] [Abstract][Full Text] [Related]
14. Malignant melanoma in 63 dogs (2001-2011): the effect of carboplatin chemotherapy on survival.
Brockley LK; Cooper MA; Bennett PF
N Z Vet J; 2013 Jan; 61(1):25-31. PubMed ID: 22913610
[TBL] [Abstract][Full Text] [Related]
15. Canine oral melanoma: comparison of surgery versus surgery plus Corynebacterium parvum.
MacEwen EG; Patnaik AK; Harvey HJ; Hayes AA; Matus R
Cancer Invest; 1986; 4(5):397-402. PubMed ID: 3801954
[TBL] [Abstract][Full Text] [Related]
16. Multimodality treatment including ONCEPT for canine oral melanoma: A retrospective analysis of 131 dogs.
Turek M; LaDue T; Looper J; Nagata K; Shiomitsu K; Keyerleber M; Buchholz J; Gieger T; Hetzel S
Vet Radiol Ultrasound; 2020 Jul; 61(4):471-480. PubMed ID: 32323424
[TBL] [Abstract][Full Text] [Related]
17. Prolongation of survival of dogs with oral malignant melanoma treated by en bloc surgical resection and adjuvant CSPG4-antigen electrovaccination.
Piras LA; Riccardo F; Iussich S; Maniscalco L; Gattino F; Martano M; Morello E; Lorda Mayayo S; Rolih V; Garavaglia F; De Maria R; Lardone E; Collivignarelli F; Mignacca D; Giacobino D; Ferrone S; Cavallo F; Buracco P
Vet Comp Oncol; 2017 Sep; 15(3):996-1013. PubMed ID: 27146852
[TBL] [Abstract][Full Text] [Related]
18. Combination of Suicide and Cytokine Gene Therapies as Surgery Adjuvant for Canine Mammary Carcinoma.
Finocchiaro LME; Spector AIM; Agnetti L; Arbe MF; Glikin GC
Vet Sci; 2018 Aug; 5(3):. PubMed ID: 30081470
[TBL] [Abstract][Full Text] [Related]
19. Pulse-mediated chemotherapy enhances local control and survival in a spontaneous canine model of primary mucosal melanoma.
Spugnini EP; Dragonetti E; Vincenzi B; Onori N; Citro G; Baldi A
Melanoma Res; 2006 Feb; 16(1):23-7. PubMed ID: 16432452
[TBL] [Abstract][Full Text] [Related]
20. Suicide plus immune gene therapy prevents post-surgical local relapse and increases overall survival in an aggressive mouse melanoma setting.
Villaverde MS; Combe K; Duchene AG; Wei MX; Glikin GC; Finocchiaro LM
Int Immunopharmacol; 2014 Sep; 22(1):167-75. PubMed ID: 24973616
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
